Equities

Biokarpet Industrial and Commercial Enterprises SA

BIOKA:ATH

Biokarpet Industrial and Commercial Enterprises SA

Actions
  • Price (EUR)1.67
  • Today's Change-0.02 / -1.18%
  • Shares traded7.18k
  • 1 Year change-31.84%
  • Beta0.8423
Data delayed at least 20 minutes, as of Nov 12 2024 14:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments7.715.277.52
Total Receivables, Net575247
Total Inventory384843
Prepaid expenses------
Other current assets, total0--0
Total current assets10210597
Property, plant & equipment, net897973
Goodwill, net------
Intangibles, net0.110.120.04
Long term investments3.444.585.09
Note receivable - long term0.730.270.40
Other long term assets0--0
Total assets197190177
LIABILITIES
Accounts payable333537
Accrued expenses------
Notes payable/short-term debt3.071611
Current portion long-term debt/capital leases8.621312
Other current liabilities, total5.946.324.85
Total current liabilities517165
Total long term debt947276
Total debt10510299
Deferred income tax0.910.330.04
Minority interest0.790.730.59
Other liabilities, total1.601.451.45
Total liabilities148146143
SHAREHOLDERS EQUITY
Common stock252525
Additional paid-in capital212121
Retained earnings (accumulated deficit)3.96(0.84)(12)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.61)(0.59)(0.63)
Total equity494534
Total liabilities & shareholders' equity197190177
Total common shares outstanding242424
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.